Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review

References

• Aharonovich, E., Hatzenbuehler, M. L., Johnston, B., O'Leary, A., Morgenstern, J., Wainberg, M. L., … Hasin, D. S. (2006). A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting. AIDS Care, 18(6), 561–568. 10.1080/09540120500264134.
   Google Scholar
• Alqahtani, S. A., Afdhal, N., Zeuzem, S., Gordon, S. C., Mangia, A., Kwo, P., … Sulkowski, M. (2015). Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials. Hepatology (Baltimore, Md.), 62(1), 25–30. doi:10.1002/hep.27890.
   Google Scholar
• Arain, A., & Robaeys, G. (2014). Eligibility of persons who inject drugs for treatment of hepatitis C virus infection. World Journal of Gastroenterology, 20(36), 12722–12733. doi:10.3748/wjg.v20.i36.12722.
   Google Scholar
• Blasiole, J. A., Shinkunas, L., Labrecque, D. R., Arnold, R. M., & Zickmund, S. L. (2006). Mental and physical symptoms associated with lower social support for patients with hepatitis C. World Journal of Gastroenterology, 12(29), 4665–4672.
   Google Scholar
• Brown, J. L., DeMartini, K. S., Sales, J. M., Swartzendruber, A. L., & DiClemente, R. J. (2013). Interventions to reduce alcohol use among HIV-infected individuals: A review and critique of the literature. Current HIV/AIDS Reports, 10(4), 356–370. doihttps://doi.org/10.1007/s11904-013-0174-8.
   Google Scholar
• Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011). Hepatitis C virus infection in USA: an estimate of true prevalence. Liver International?: Official Journal of the International Association for the Study of the Liver, 31(8), 1090–1101. doi:10.1111/j.1478-3231.2011.02494.x.
   Google Scholar
• Dieperink, E., Fuller, B., Isenhart, C., McMaken, K., Lenox, R., Pocha, C., … Hauser, P. (2014). Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: A randomized controlled trial. Addiction (Abingdon, England), 109(11), 1869–1877. doi:10.1111/add.12679.
   Google Scholar
• Dieperink, E., Ho, S. B., Heit, S., Durfee, J. M., Thuras, P., & Willenbring, M. L. (2010). Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic. Psychosomatics, 51(2), 149–156. doi:10.1176/appi.psy.51.2.149.
   Google Scholar
• Drumright, L. N., Hagan, H., Thomas, D. L., Latka, M. H., Golub, E. T., Garfein, R. S., … Strathdee, S. A. (2011). Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. Journal of Hepatology, 55(1), 45–52. doi:10.1016/j.jhep.2010.10.028.
   Google Scholar
• Evon, D. M., Esserman, D. A., Ramcharran, D., Bonner, J. E., & Fried, M. W. (2011). Social support and clinical outcomes during antiviral therapy for chronic hepatitis C. Journal of Psychosomatic Research, 71(5), 349–356. doi:10.1016/j.jpsychores.2011.05.003.
   Google Scholar
• Evon, D. M., Simpson, K., Kixmiller, S., Galanko, J., Dougherty, K., Golin, C., & Fried, M. W. (2011). A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment. American Journal of Gastroenterology, 106(10), 1777–1786. doi:10.1038/ajg.2011.219.
   Google Scholar
• First, M. B. (2002). Structured clinical interview for DSM-IV-TR Axis I disorders. New York, NY: Biometrics Research Department.
   Google Scholar
• Flickinger, T. E., Rose, G., Wilson, I. B., Wolfe, H., Saha, S., Korthuis, P. T., … Beach, M. C. (2013). Motivational interviewing by HIV care providers is associated with patient intentions to reduce unsafe sexual behavior. Patient Education and Counseling, 93(1), 122–129. doi:10.1016/j.pec.2013.04.001.
   Google Scholar
• Fontana, R. J., Kronfol, Z., Lindsay, K. L., Bieliauskas, L. A., Padmanabhan, L., Back-Madruga, C., … Stoddard, A. M. (2008). Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C. American Journal of Gastroenterology, 103(11), 2755–2766. doi:10.1111/j.1572-0241.2008.02106.x.
   Google Scholar
• Fuster, D., Sanvisens, A., Bolao, F., Serra, I., Rivas, I., Tor, J., & Muga, R. (2015). Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients. Journal of Viral Hepatitis, 22(1), 18–24. doi:10.1111/jvh.12290.
   Google Scholar
• Gidding, H. F., Law, M. G., Amin, J., Macdonald, G. A., Sasadeusz, J. J., Jones, T. L., … Dore, G. J. (2011). Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Medical Journal of Australia, 194(8), 398–402.
   Google Scholar
• Greaves, C. J., Middlebrooke, A., O'Loughlin, L., Holland, S., Piper, J., Steele, A., … Daly, M. (2008). Motivational interviewing for modifying diabetes risk: A randomised controlled trial. British Journal of General Practice?: The Journal of the Royal College of General Practitioners, 58(553), 535–540. doi:10.3399/bjgp08X319648.
   Google Scholar
• Grebely, J., Genoway, K. A., Raffa, J. D., Dhadwal, G., Rajan, T., Showler, G., … Fischer, B. (2008). Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug and Alcohol Dependence, 93(1/2), 141–147. doi:10.1016/j.drugalcdep.2007.09.008.
   Google Scholar
• Grebely, J., Haire, B., Taylor, L. E., Macneill, P., Litwin, A. H., Swan, T., … Dore, G. J. (2015). Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data? Journal of Hepatology 63(4), 779–782. doi:10.1016/j.jhep.2015.06.014.
   Google Scholar
• Lavanchy, D. (2011). Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection, 17(2), 107–115. doi:10.1111/j.1469-0691.2010.03432.x.
   Google Scholar
• Ly, K. N., Xing, J., Klevens, R. M., Jiles, R. B., & Holmberg, S. D. (2013). Causes of death and characteristics of decedents with viral hepatitis, United States, 2010. Clinical Infectious Diseases?: An Official Publication of the Infectious Diseases Society of Americ, 58(1), 40–49. doi:10.1093/cid/cit642.
   Google Scholar
• Marinho, R. T., & Barreira, D. P. (2013). Hepatitis C, stigma and cure. World Journal of Gastroenterology, 19(40), 6703–6709. doi:10.3748/wjg.v19.i40.6703.
   Google Scholar
• McCartney, E. M., & Beard, M. R. (2010). Impact of alcohol on hepatitis C virus replication and interferon signaling. World Journal of Gastroenterology, 16(11), 1337–1343.
   Google Scholar
• McGahan, P., Griffith, J., Parente, R., & McLellan, A. (1986). Addiction severity index composite scores manual. Retrieved from http://www.tresearch.org/wp-content/uploads/2012/09/ASIQbyQGuide.pdf.
   Google Scholar
• Miller, W., & Rollnick, S. (2013). Motivational Interviewing: Helping people change (3rd ed.). New York, NY: Guilford.
   Google Scholar
• Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. t. (2013). Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, Md.), 57(4), 1333–1342. doi:10.1002/hep.26141.
   Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ (Clinical Research Ed.), 339, b2535.
   Google Scholar
• Moyer, A., & Finney, J. W. (2004). Brief interventions for alcohol problems: Factors that facilitate implementation. Alcohol Research & Health?: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 28(1), 44–50.
   Google Scholar
• Naar-King, S., Lam, P., Wang, B., Wright, K., Parsons, J. T., & Frey, M. A. (2008). Brief report: Maintenance of effects of motivational enhancement therapy to improve risk behaviors and HIV-related Health in a randomized controlled trial of youth living with HIV. Journal of Pediatric Psychology, 33(4), 441–445. doi:10.1093/jpepsy/jsm087.
   Google Scholar
• North, C. S., Hong, B. A., Adewuyi, S. A., Pollio, D. E., Jain, M. K., Devereaux, R., … Lisker-Melman, M. (2013). Hepatitis C treatment and SVR: The gap between clinical trials and real-world treatment aspirations. General Hospital Psychiatry, 35(2), 122–128. doi:10.1016/j.genhosppsych.2012.11.002.
   Google Scholar
• North, C. S., Sims, O., Hong, B. A., Jain, M. K., Brown, G., Lisker-Melman, M., & Pollio, D. E. (2014). An empirical study of alcohol consumption by patients considering HCV treatment. American Journal of Drug and Alcohol Abuse, 40(6), 484–489. doi:10.3109/00952990.2014.945592.
   Google Scholar
• Osna, N. A., Ganesan, M., & Kharbanda, K. K. (2015). Hepatitis C, innate immunity and alcohol: friends or foes? Biomolecules, 5(1), 76–94. doi:10.3390/biom5010076.
   Google Scholar
• Parsons, J. T., Lelutiu-Weinberger, C., Botsko, M., & Golub, S. A. (2014). A randomized controlled trial utilizing motivational interviewing to reduce HIV risk and drug use in young gay and bisexual men. Journal of Consulting and Clinical Psychology, 82(1), 9–18. doi:10.1037/a0035311.
   Google Scholar
• Proeschold-Bell, R. J., Patkar, A. A., Naggie, S., Coward, L., Mannelli, P., Yao, J., … Muir, A. J. (2012). An integrated alcohol abuse and medical treatment model for patients with hepatitis C. Digestive Diseases and Sciences, 57(4), 1083–1091. doi:10.1007/s10620-011-1976-4.
   Google Scholar
• Rongkavilit, C., Wang, B., Naar-King, S., Bunupuradah, T., Parsons, J. T., Panthong, A., … Phanuphak, P. (2014). Motivational Interviewing targeting risky sex in HIV-positive young Thai Men who have sex with men. Archives of Sexual Behavior, 44(2), 329–340. doi:10.1007/s10508-014-0274-6.
   Google Scholar
• Saunders, J. B., Aasland, O. G., Babor, T. F., De La Fuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction, 88, 791–804.
   Google Scholar
• Shah, H. A., & Abu-Amara, M. (2013). Education provides significant benefits to patients with Hepatitis B Virus or Hepatitis C Virus infection: A systematic review. Clinical Gastroenterology and Hepatology?: The Official Clinical Practice Journal of the American Gastroenterological Association, 11(8), 922–933. doi:10.1016/j.cgh.2013.04.024.
   Google Scholar
• Sims, O. T., Whalen, C. C., Nackerud, L. G., & Bride, B. E. (2013). Birth cohort testing for hepatitis C virus: Implications for clinical social workers in health care settings. Social Work in Health Care, 52(8), 689–703. doi:10.1080/00981389.2013.806385.
   Google Scholar
• Sims, O. T., & Womack, B. G. (2015). Hepatitis C and HIV coinfection for social workers in public health, medical and substance use treatment settings. Social Work in Public Health, 30(4), 325–335. doi:10.1080/19371918.2014.1000506.
   Google Scholar
• Szabo, G., Aloman, C., Polyak, S. J., Weinman, S. A., Wands, J., & Zakhari, S. (2006). Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity. Alcoholism, Clinical and Experimental Research, 30(4), 709–719. doi:10.1111/j.1530-0277.2006.00083.x.
   Google Scholar
• Szabo, G., Wands, J. R., Eken, A., Osna, N. A., Weinman, S. A., Machida, K., & Joe Wang, H. (2010). Alcohol and hepatitis C virus–Interactions in immune dysfunctions and liver damage. Alcoholism. Clinical and Experimental Research, 34(10), 1675–1686. doi:10.1111/j.1530-0277.2010.01255.x.
   Google Scholar
• VanBuskirk, K. A., & Wetherell, J. L. (2014). Motivational interviewing with primary care populations: a systematic review and meta-analysis. Journal of Behavioral Medicine, 37(4), 768–780. doi:10.1007/s10865-013-9527-4.
   Google Scholar
• Wyles, D., Pockros, P., Morelli, G., Younes, Z., Svarovskaia, E., Yang, J. C., … Lawitz, E. (2015). Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens. Hepatology (Baltimore, Md.), 61(1), 1793–1797. doi:10.1002/hep.27814.
   Google Scholar
• Younossi, Z. M., Zheng, L., Stepanova, M., Venkatesan, C., & Mir, H. M. (2013). Moderate, excessive or heavy alcohol consumption: Each is significantly associated with increased mortality in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics, 37(7), 703–709. doi:10.1111/apt.12265.
   Google Scholar
• Zeremski, M., Zibbell, J. E., Martinez, A. D., Kritz, S., Smith, B. D., & Talal, A. H. (2013). Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World Journal of Gastroenterolog, 19(44), 7846–7851. doi:10.3748/wjg.v19.i44.7846.
   Google Scholar
• Zule, W. A., Costenbader, E. C., Coomes, C. M., & Wechsberg, W. M. (2009). Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users. American Journal of Public Health, 99(Suppl 1), S180–S186. doi:10.2105/AJPH.2007.126854.
   Google Scholar